XML 65 R37.htm IDEA: XBRL DOCUMENT v3.10.0.1
Fair Value of Financial Instruments (Tables)
 12 Months Ended
Jun. 02, 2018
Fair Value Disclosures [Abstract]  
Schedule of Fair Value by Balance Sheet Grouping
The carrying value and fair value of the company's long-term debt, including current maturities, is as follows for the periods indicated:
(In millions)
 
June 2, 2018
 
June 3, 2017
Carrying value
 
$
285.8

 
$
210.1

Fair value
 
$
288.6

 
$
223.2
Schedule of Fair Value Assets and Liabilities Measured on a Recurring and Nonrecurring Basis
The following tables set forth financial assets and liabilities measured at fair value in the Consolidated Balance Sheets and the respective pricing levels to which the fair value measurements are classified within the fair value hierarchy as of June 2, 2018 and June 3, 2017:
 
Fair Value Measurements
 
June 2, 2018
 
June 3, 2017
(In millions)
Financial Assets
Quoted Prices With Other Observable Inputs (Level 2)
Management Estimates (Level 3)
 
Quoted Prices With Other Observable Inputs (Level 2)
Management Estimates (Level 3)
Cash Equivalents
$
121.0

$
—

 
$
—

$
—

Available-for-sale securities:
 
 
 
 
 
Mutual funds - fixed income
7.7

—

 
7.7

—

Mutual funds - equity
0.9

—

 
0.9

—

Foreign currency forward contracts
0.4

—

 
0.5

—

Interest rate swap agreement
15.0

—

 
3.3

—

Deferred compensation plan
15.1

—

 
12.8

—

Total
$
160.1

$
—

 
$
25.2

$
—

 
 
 
 
 
 
Financial Liabilities
 
 
 
 
 
Foreign currency forward contracts
$
0.3

$
—

 
$
0.6

$
—

Contingent consideration
—

0.5

 
—

0.5

Total
$
0.3

$
0.5

 
$
0.6

$
0.5
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation
The table below presents a reconciliation for liabilities measured at fair value using significant unobservable inputs (Level 3) (in millions):
(In millions)
 
 
 
Contingent Consideration
June 2, 2018
 
June 3, 2017
Beginning balance
$
0.5

 
$
2.7

Net realized losses (gains)
0.1

 
(0.2
)
Settlements
(0.1
)
 
(2.0
)
Ending balance
$
0.5

 
$
0.5
Schedule of Unrealized Gain (Loss) on Investments
The following is a summary of the carrying and market values of the company's marketable securities as of the dates indicated:
 
June 2, 2018
 
June 3, 2017
(In millions)
Cost
 
Unrealized Gain
 
Unrealized Loss
 
Market Value
 
Cost
 
Unrealized Gain
 
Unrealized Loss
 
Market Value
Mutual funds - fixed income
$
7.8

 
$
—

 
$
0.1

 
$
7.7

 
$
7.6

 
$
0.1

 
$
—

 
$
7.7

Mutual funds - equity
0.7

 
0.2

 
—

 
0.9

 
0.9

 
—

 
—

 
0.9

Total
$
8.5

 
$
0.2

 
$
0.1

 
$
8.6

 
$
8.5

 
$
0.1

 
$
—

 
$
8.6
Schedule of Derivatives Instruments Statements of Financial Performance and Financial Position, Location
effects of derivatives on the consolidated financial statements were as follows for the fiscal years ended 2018 and 2017 (amounts presented exclude any income tax effects):
(In millions)
Balance Sheet Location
 
June 2, 2018
 
June 3, 2017
Designated derivatives:
 
 
 
 
 
Interest rate swap
Long-term assets: Other assets
 
$
15.0

 
$
3.3

Non-designated derivatives:
 
 
 
 
 
Foreign currency forward contracts
Current assets: Other
 
$
0.4

 
$
0.5

Foreign currency forward contracts
Current liabilities: Other accrued liabilities
 
$
0.3

 
$
0.6


 
 
 
Fiscal Year
(In millions)
Statement of Comprehensive Income Location
 
June 2, 2018
 
June 3, 2017
 
May 28, 2016
Gain recognized on foreign currency forward contracts
Other expenses (income): Other, net
 
$
0.4

 
$
(1.2
)
 
$
(0.7
)
Schedule of Derivative Instruments, Effect on Other Comprehensive Income (Loss)
The gain recorded, net of income taxes, in Other comprehensive loss for the effective portion of designated derivatives was as follows for the periods presented below:
 
Fiscal Year
(In millions)
June 2, 2018
 
June 3, 2017
 
May 28, 2016
Interest rate swap
$
7.5

 
$
2.1

 
$
—